From Our Perspective

Lilly Moves to Undermine 340B Again

Eli Lilly and Company has made good sport of undermining the 340B Drug Discount Program and is once again bullying safety-net hospitals – this time with unworkable and burdensome administrative ...

Big Pharma’s 340B Heist Just Hit a Dead End

The Trump Administration has for now abandoned a stunningly ill-conceived plan to turn the 340B Drug Discount Program into a rebate.Health and Human Services Secretary Robert F. Kennedy, Jr. pulled ...

Secretary Kennedy’s Opportunity to End Big Pharma’s Grip on HRSA

The American Hospital Association has filed an explosive lawsuit attacking the Health Resources and Services Administration’s handling of a flawed 340B Drug Discount Program rebate scheme.The plaintiffs charge that HRSA is in ...

Anti-340B Hearing Goes Off The Rails

Sen. Bill Cassidy (R-LA) was hoping to savage the 340B Drug Discount Program during a Capitol Hill hearing on October 23rd. But several of his Republican colleagues foiled the plan.Cassidy ...

340B Rebates: A Truly Terrible Idea

The drug industry continues its efforts to eviscerate the 340B Drug Discount Program through a proposed rebate pilot program. Of the more than 1,200 comments posted to the Health Resources ...

Want To Stay Up-To-Date On The Latest 340B News?

"*" indicates required fields